NM

Neuroone Medical Technologies CorpNASDAQ NMTC Stock Report

Last reporting period 30 Jun, 2024

Updated 25 Nov, 2024

Last price

Market cap $B

0.031

Micro

Exchange

XNAS - Nasdaq

NMTC Stock Analysis

NM

Uncovered

Neuroone Medical Technologies Corp is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

8/100

Low score

Market cap $B

0.031

Dividend yield

Shares outstanding

16.364 B

NeuroOne Medical Technologies Corporation (NeuroOne) is a medical technology company. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spin al cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It is also investigating the applications of its technology associated with artificial intelligence. It develops its cortical, sheet and depth electrode technology to provide solutions for diagnosis through cEEG recording and sEEG recording and treatment through brain stimulation and ablation. Its commercialized product, Evo sEEG electrode technology records, monitors and stimulates electrical signals at the subsurface level of the brain.

View Section: Eyestock Rating